Related Experiment Video
Updated: Jun 14, 2026
03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
Continuous glucose monitoring
1Atlanta Diabetes Associates77 Collier Rd. Suite 2080, Atlanta, GA 30309, USA. bode001@aol.com
International Journal of Clinical Practice. Supplement
|April 10, 2010
Summary
Real-time continuous glucose monitoring (RT-CGM) significantly lowers HbA1c in type 1 diabetes patients. This technology improves metabolic control compared to traditional blood glucose monitoring.
Area of Science:
- Endocrinology
- Medical Technology
Background:
- Real-time continuous glucose monitoring (RT-CGM) offers transformative potential for type 1 diabetes (T1D) management.
- Recent advancements include approved devices for interstitial fluid monitoring, complementing self-monitoring of blood glucose (SMBG).
Purpose of the Study:
- To evaluate the efficacy of RT-CGM in improving glycemic control in individuals with T1D.
- To assess the impact of RT-CGM on HbA1c levels compared to SMBG.
Main Methods:
- Utilized data from randomized controlled trials (RCTs) involving RT-CGM devices.
- Compared outcomes between groups using RT-CGM continuously and a control group using SMBG.
Main Results:
- The first RCT showed a significant HbA1c decrease in adult and pediatric T1D patients using RT-CGM for 3 months.
- Recent RCTs confirm RT-CGM's significant HbA1c reduction capabilities.
- Retrospective analysis of CGM data indicates positive metabolic control effects in both T1D and type 2 diabetes.
Conclusions:
- RT-CGM is a valuable tool for improving glycemic control in individuals with T1D.
- The technology demonstrates significant HbA1c reduction and positive impacts on metabolic control across diabetes types.
Related Concept Videos
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...